Company Overview and News
Testing of West Australian waste water has revealed Perth’s ice epidemic is easing with the city recording its lowest levels of methamphetamine use since records began in 2016.
THE strengthening Singapore dollar suggests that the market expects further monetary tightening, yet economists are divided over whether the Monetary Authority of Singapore (MAS) will do so in its upcoming half-yearly policy review, with inflation in the upper half of the official forecast range but growth slowing amid global risks.
STAN DB 580001 STAB STAN STAC 2888 SCBFF APR APRLY
Hyper-growth digital education company Chegg (NYSE:CHGG) recently announced an April data breach that exposed information on 40 million of the company’s users. In the wake of the news, CHGG stock traded down more than 10%.
TGT AMZN EFX VZ CHGG APR APRLY
VANCOUVER, British Columbia, Sept. 26, 2018 (GLOBE NEWSWIRE) -- Canada Carbon Inc. (the “Company”) (TSX-V:CCB), (FF:U7N1) is pleased to announce the signing of a non-binding Memorandum of Understanding ("MOU") for the supply of the Company’s Miller nuclear purity graphite to Dunedin Energy Systems Ltd, an arm’s length Canadian developer of small modular nuclear reactors. The MOU terms are for the supply of 200 tonnes per annum of Miller nuclear purity graphite over a 10-year term, with a floor price of USD $40,000 per tonne.
HIE TTEK MALRY MALRF APR CCB APRLY MIN BRUZF
The US Treasury is due in October to submit its biannual report to Congress on what countries, if any, are manipulating their currencies to gain unfair trade advantage. President Trump has recently resumed the accusation against China that he made during the election campaign. "I think China's manipulating their currency, absolutely. And I think the euro is being manipulated also," he told Reuters.
In case you missed out on previous editions of this newsletter, simply click here, here or here to catch up.
OCANF EMRRF LUNMF CNL MUN NSU FNLPF TGB THO MUX.RTWI MAG EVM MUNMF MUX SEMFF NEVDF ABX TAHO GPL MUX OKSWF CDEUW BGMZF DRGDF CDE LYDIF NCU OSKGF MAG APR APRLY TKO EXK NEM CPNFD CGOOF LUNCF GSV TECK DGC EDVVF OR TCKRF EDR GG EDV ABX EDVMF DPMLF LUN EVR
FILE - In this March 12, 2016 file photo, actor Burt Reynolds appears at the world premiere of "The Bandit" during the South by Southwest Film Festival in Austin, Texas. Reynolds, who starred in films including "Deliverance," "Boogie Nights," and the "Smokey and the Bandit" films, died at age 82, according to his agent. (Photo by Jack Plunkett/Invision/AP, File)
In this Aug. 22, 2015 file photo, Burt Reynolds appears at the Wizard World Chicago Comic-Con in Chicago. Reynolds, who starred in films including “Deliverance”, “Boogie Nights”, and the “Smokey and the Bandit” films, died at age 82, according to his agent. Image: Invision/Barry Brecheisen via AP
Burt Reynolds, the handsome film and television star known for his acclaimed performances in Deliverance and Boogie Nights, and for an active off-screen love life which included relationships with Loni Anderson and Sally Field, died on Thursday at age 82.
Good day, ladies and gentlemen. And welcome to the Toro Company's Third Quarter Earnings Conference Call. My name is Ashley and I'll be your coordinator for today. At this time, all participants are in a listen-only mode. We will be facilitating a question-and-answer session towards the end of today's conference [Operator Instructions]. As a reminder, this conference is being recorded for replay purposes.
TTC APR TORO APRLY
This copy is for your personal non-commercial use only. To order presentation-ready copies of Toronto Star content for distribution to colleagues, clients or customers, or inquire about permissions/licensing, please go to: www.TorontoStarReprints.com
Since bursting onto the public scene a short four months ago, Spotify (NYSE:SPOT) stock has been a well-behaved gift to bulls. The proof is in its price action, which has been healthy with nary a misstep. Dips are being bought and breakouts chased. It’s just the type of stock that belongs on a trend traders watchlist.
SPOT APR APRLY
2018-10-01 - Asif
Overview The following discussion and analysis should be read in conjunction with its unaudited interim condensed consolidated financial statements and the related notes that appear elsewhere in this quarterly report on Form 10-Q. This discussion contains forward-looking statements reflecting its current expectations that involve risks and uncertainties. Actual results may differ materially from those discussed in these forward-looking statements due to a number of factors, including those set forth in the section entitled “Risk Factors” in its most recent annual report on Form 10-K. For further information regarding forward-looking statements, please refer to the “Special Note Regarding Forward-Looking Statements and Projections” immediately after the index to this quarterly report on Form 10-Q. Alimera Sciences, Inc., and its subsidiaries (we or Alimera), is a pharmaceutical company that specializes in the commercialization and development of prescription ophthalmic pharma...
2018-09-25 - Asif
Background DelMar Pharmaceuticals, Inc. is a clinical stage drug development company with a focus on the treatment of cancer. The company's mission is to benefit patients and create shareholder value by developing and commercializing anti-cancer therapies for patients whose tumors exhibit features that make them resistant to, or unlikely to respond to, currently available therapies, particularly for orphan cancer indications where patients have failed, or are unlikely to respond to, currently available therapy. DelMar Pharmaceuticals is developing VAL-083, a novel, DNA-targeting agent, for the treatment of glioblastoma multiforme (“GBM”) and potentially other solid tumors, including ovarian cancer. VAL-083 is a first-in-class, DNA-targeting chemotherapeutic that demonstrated activity against a range of tumor types in prior Phase 1 and Phase 2 clinical studies sponsored by the US National Cancer Institute (“NCI”). The company's recent research has highlighted the opportunit...
2018-09-18 - Asif
Overview Rigel Pharmaceuticals is a biotechnology company dedicated to discovering, developing and providing novel small molecule drugs that significantly improve the lives of patients with immune and hematologic disorders, cancer and rare diseases. The company's pioneering research focuses on signaling pathways that are critical to disease mechanisms. The company's first FDA-approved product is TAVALISSE™ (fostamatinib disodium hexahydrate), an oral spleen tyrosine kinase (SYK) inhibitor, for the treatment of adult patients with chronic immune thrombocytopenia who have had an insufficient response to a previous treatment. The company's current clinical programs include Phase 2 studies of fostamatinib in autoimmune hemolytic anemia and IgA nephropathy, and a Phase 1 study for its IRAK program. In addition, Rigel Pharmaceuticals has product candidates in development with partners BerGenBio AS, Daiichi Sankyo, and Aclaris Therapeutics. Since inception, Rigel Pharmaceuticals h...
Silicon Investor Message Boards
This table lists all message boards related to EPA:APR / APRIL on message board site Silicon Investor.